Literature DB >> 21705623

ML1419c peptide immunization induces Mycobacterium leprae-specific HLA-A*0201-restricted CTL in vivo with potential to kill live mycobacteria.

Annemieke Geluk1, Susan J F van den Eeden, Karin Dijkman, Louis Wilson, Hee Jin Kim, Kees L M C Franken, John S Spencer, Maria C V Pessolani, Geraldo M B Pereira, Tom H M Ottenhoff.   

Abstract

MHC class I-restricted CD8(+) T cells play an important role in protective immunity against mycobacteria. Previously, we showed that p113-121, derived from Mycobacterium leprae protein ML1419c, induced significant IFN-γ production by CD8(+) T cells in 90% of paucibacillary leprosy patients and in 80% of multibacillary patients' contacts, demonstrating induction of M. leprae-specific CD8(+) T cell immunity. In this work, we studied the in vivo role and functional profile of ML1419c p113-121-induced T cells in HLA-A*0201 transgenic mice. Immunization with 9mer or 30mer covering the p113-121 sequence combined with TLR9 agonist CpG induced HLA-A*0201-restricted, M. leprae-specific CD8(+) T cells as visualized by p113-121/HLA-A*0201 tetramers. Most CD8(+) T cells produced IFN-γ, but distinct IFN-γ(+)/TNF-α(+) populations were detected simultaneously with significant secretion of CXCL10/IFN-γ-induced protein 10, CXCL9/MIG, and VEGF. Strikingly, peptide immunization also induced high ML1419c-specific IgG levels, strongly suggesting that peptide-specific CD8(+) T cells provide help to B cells in vivo, as CD4(+) T cells were undetectable. An additional important characteristic of p113-121-specific CD8(+) T cells was their capacity for in vivo killing of p113-121-labeled, HLA-A*0201(+) splenocytes. The cytotoxic function of p113-121/HLA-A*0201-specific CD8(+) T cells extended into direct killing of splenocytes infected with live Mycobacterium smegmatis expressing ML1419c: both 9mer and 30mer induced CD8(+) T cells that reduced the number of ML1419c-expressing mycobacteria by 95%, whereas no reduction occurred using wild-type M. smegmatis. These data, combined with previous observations in Brazilian cohorts, show that ML1419c p113-121 induces potent CD8(+) T cells that provide protective immunity against M. leprae and B cell help for induction of specific IgG, suggesting its potential use in diagnostics and as a subunit (vaccine) for M. leprae infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705623      PMCID: PMC3140574          DOI: 10.4049/jimmunol.1100980

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

Authors:  Giuseppe Pantaleo; Alexandre Harari
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

2.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.

Authors:  Patricia A Darrah; Dipti T Patel; Paula M De Luca; Ross W B Lindsay; Dylan F Davey; Barbara J Flynn; Søren T Hoff; Peter Andersen; Steven G Reed; Sheldon L Morris; Mario Roederer; Robert A Seder
Journal:  Nat Med       Date:  2007-06-10       Impact factor: 53.440

3.  CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity.

Authors:  Martijn S Bijker; Susan J F van den Eeden; Kees L Franken; Cornelis J M Melief; Rienk Offringa; Sjoerd H van der Burg
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

Review 4.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.

Authors:  Annemieke Geluk; John S Spencer; Kidist Bobosha; Maria C V Pessolani; Geraldo M B Pereira; Sayera Banu; Nadine Honoré; Stephen T Reece; Murdo MacDonald; Bishwa Raj Sapkota; Chaman Ranjit; Kees L M C Franken; Martha Zewdie; Abraham Aseffa; Rabia Hussain; Mariane M Stefani; Sang-Nae Cho; Linda Oskam; Patrick J Brennan; Hazel M Dockrell
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

6.  Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Nigel D L Savage; Tjitske de Boer; Frédéric Triebel; Annemieke van der Wal; Emile de Heer; Michèl R Klein; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

7.  Use of protein antigens for early serological diagnosis of leprosy.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Ludimila P V Cardoso; Celina M T Martelli; Mariane M A Stefani; Maria Nakatani; Robson Crusue de Jesus; Eduardo M Netto; Ma V F Balagon; Esterlina Tan; Robert H Gelber; Yumi Maeda; Masahiko Makino; Dan Hoft; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

8.  Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1.

Authors:  Rolf Billeskov; Carina Vingsbo-Lundberg; Peter Andersen; Jes Dietrich
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

9.  Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.

Authors:  Annemieke Geluk; Jolien van der Ploeg; Rose O B Teles; Kees L M C Franken; Corine Prins; Jan Wouter Drijfhout; Euzenir N Sarno; Elizabeth P Sampaio; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2008-01-16

10.  Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.

Authors:  Morten Ruhwald; Janne Petersen; Kristian Kofoed; Hiroshi Nakaoka; Luis Eduardo Cuevas; Lovett Lawson; Stephen Bertil Squire; Jesper Eugen-Olsen; Pernille Ravn
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  4 in total

1.  Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.

Authors:  Mariateresa Coppola; Susan J F van den Eeden; Louis Wilson; Kees L M C Franken; Tom H M Ottenhoff; Annemieke Geluk
Journal:  Clin Vaccine Immunol       Date:  2015-07-22

2.  Diguanylate cyclase activity of the Mycobacterium leprae T cell antigen ML1419c.

Authors:  Suwatchareeporn Rotcheewaphan; John T Belisle; Kristofor J Webb; Hee-Jin Kim; John S Spencer; Bradley R Borlee
Journal:  Microbiology (Reading)       Date:  2016-07-22       Impact factor: 2.777

3.  Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine.

Authors:  Negar Seyed; Tahereh Taheri; Charline Vauchy; Magalie Dosset; Yann Godet; Ali Eslamifar; Iraj Sharifi; Olivier Adotevi; Christophe Borg; Pierre Simon Rohrlich; Sima Rafati
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

Review 4.  Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.

Authors:  Mariateresa Coppola; Susan J F van den Eeden; Naoko Robbins; Louis Wilson; Kees L M C Franken; Linda B Adams; Tom P Gillis; Tom H M Ottenhoff; Annemieke Geluk
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.